These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 19502990

  • 41. Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women.
    Ngemu EK, Khayeka-Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E.
    BMC Res Notes; 2014 Jan 21; 7():52. PubMed ID: 24447387
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.
    AIDS; 2008 Sep 12; 22(14):1815-20. PubMed ID: 18753864
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Strategies to prevent mother-to-child transmission of HIV.
    McIntyre J.
    Curr Opin Infect Dis; 2006 Feb 12; 19(1):33-8. PubMed ID: 16374215
    [Abstract] [Full Text] [Related]

  • 46. Current treatment strategies, complications and considerations for the use of HIV antiretroviral therapy during pregnancy.
    Senise JF, Castelo A, Martínez M.
    AIDS Rev; 2011 Feb 12; 13(4):198-213. PubMed ID: 21975356
    [Abstract] [Full Text] [Related]

  • 47. Emergence of minor drug-resistant HIV-1 variants after triple antiretroviral prophylaxis for prevention of vertical HIV-1 transmission.
    Hauser A, Sewangi J, Mbezi P, Dugange F, Lau I, Ziske J, Theuring S, Kuecherer C, Harms G, Kunz A.
    PLoS One; 2012 Feb 12; 7(2):e32055. PubMed ID: 22384138
    [Abstract] [Full Text] [Related]

  • 48. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
    Thior I, Lockman S, Smeaton LM, Shapiro RL, Wester C, Heymann SJ, Gilbert PB, Stevens L, Peter T, Kim S, van Widenfelt E, Moffat C, Ndase P, Arimi P, Kebaabetswe P, Mazonde P, Makhema J, McIntosh K, Novitsky V, Lee TH, Marlink R, Lagakos S, Essex M, Mashi Study Team.
    JAMA; 2006 Aug 16; 296(7):794-805. PubMed ID: 16905785
    [Abstract] [Full Text] [Related]

  • 49. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection.
    Suksomboon N, Poolsup N, Ket-Aim S.
    J Clin Pharm Ther; 2007 Jun 16; 32(3):293-311. PubMed ID: 17489882
    [Abstract] [Full Text] [Related]

  • 50. Emergence of NNRTI drug resistance mutations after single-dose nevirapine exposure in HIV type 1 subtype C-infected infants in India.
    Kurle SN, Gangakhedkar RR, Sen S, Hayatnagarkar SS, Tripathy SP, Paranjape RS.
    AIDS Res Hum Retroviruses; 2007 May 16; 23(5):682-5. PubMed ID: 17530993
    [Abstract] [Full Text] [Related]

  • 51. Decay of K103N mutants in cellular DNA and plasma RNA after single-dose nevirapine to reduce mother-to-child HIV transmission.
    Loubser S, Balfe P, Sherman G, Hammer S, Kuhn L, Morris L.
    AIDS; 2006 Apr 24; 20(7):995-1002. PubMed ID: 16603851
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial.
    Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, Sherman J, Bakaki P, Ducar C, Deseyve M, Emel L, Mirochnick M, Fowler MG, Mofenson L, Miotti P, Dransfield K, Bray D, Mmiro F, Jackson JB.
    Lancet; 1999 Sep 04; 354(9181):795-802. PubMed ID: 10485720
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R, Paredes R, Parboosing R, Moodley P, Gordon M.
    AIDS Rev; 2014 Sep 04; 16(4):187-98. PubMed ID: 25300623
    [Abstract] [Full Text] [Related]

  • 56. Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
    Jourdain G, Wagner TA, Ngo-Giang-Huong N, Sirirungsi W, Klinbuayaem V, Fregonese F, Nantasen I, Techapornroong M, Halue G, Nilmanat A, Wittayapraparat P, Chalermpolprapa V, Pathipvanich P, Yuthavisuthi P, Frenkel LM, Lallemant M, Program for HIV Prevention and Treatment (PHPT) Study Group.
    Clin Infect Dis; 2010 May 15; 50(10):1397-404. PubMed ID: 20377404
    [Abstract] [Full Text] [Related]

  • 57. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
    Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH.
    AIDS Res Hum Retroviruses; 2005 Apr 15; 21(4):319-24. PubMed ID: 15943576
    [Abstract] [Full Text] [Related]

  • 58. Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero.
    Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH.
    AIDS; 2010 Jan 28; 24(3):381-6. PubMed ID: 19996936
    [Abstract] [Full Text] [Related]

  • 59. Effectiveness of short-term and long-term zidovudine prophylaxis on detection of HIV-1 subtype E in human placenta and vertical transmission.
    Bhoopat L, Khunamornpong S, Lerdsrimongkol P, Sirivatanapa P, Sethavanich S, Limtrakul A, Gomutbuthra V, Kajanavanich S, Thorner PS, Bhoopat T.
    J Acquir Immune Defic Syndr; 2005 Dec 15; 40(5):545-50. PubMed ID: 16284530
    [Abstract] [Full Text] [Related]

  • 60. Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.
    Basson AE, Ntsala M, Martinson N, Tlale E, Corrigan GE, Shao X, Gray G, McIntyre J, Puren A, Morris L.
    J Acquir Immune Defic Syndr; 2008 Dec 15; 49(5):538-43. PubMed ID: 18989222
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.